Mutant Gly482 and Thr482 ABCG2 mediate high-level resistance to lipophilic antifolates

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Cancer Chemotherapy and Pharmacology

• Publication date

  2006-04-13

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00280-006-0230-9PMID 16612649
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Breast cancer resistance protein (BCRP/ABCG2).

  2005cited by this paper
• ABCG2 harboring the Gly482 mutation confers high-level resistance to various hydrophilic antifolates.

  2005influential reference
• Mutations

  2004cited by this paper
• Characterization of Oligomeric Human Half-ABC Transporter ATP-binding Cassette G2*

  2004cited by this paper
• ABCG2 – a transporter for all seasons

  2004cited by this paper
• Mutational analysis of ABCG2: role of the GXXXG motif.

  2004cited by this paper
• Folate Deprivation Results in the Loss of Breast Cancer Resistance Protein (BCRP/ABCG2) Expression

  2004cited by this paper
• Predicting P-glycoprotein substrates by a quantitative structure-activity relationship model.

  2004cited by this paper
• The MRP-related and BCRP/ABCG2 multidrug resistance proteins: biology, substrate specificity and regulation.

  2004cited by this paper
• Wild-type breast cancer resistance protein (BCRP/ABCG2) is a methotrexate polyglutamate transporter.

  2003cited by this paper
• Thymidylate synthase inhibitors as anticancer agents: from bench to bedside

  2003influential reference
• The MRP family of drug efflux pumps

  2003cited by this paper
• P-glycoprotein: from genomics to mechanism

  2003influential reference
• Novel antifolate drugs

  2003influential reference
• Transport of methotrexate, methotrexate polyglutamates, and 17beta-estradiol 17-(beta-D-glucuronide) by ABCG2: effects of acquired mutations at R482 on methotrexate transport.

  2003cited by this paper
• Loss of folylpoly‐γ‐glutamate synthetase activity is a dominant mechanism of resistance to polyglutamylation‐dependent novel antifolates in multiple human leukemia sublines

  2003influential reference
• Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C.

  2002cited by this paper
• Dominant‐negative inhibition of breast cancer resistance protein as drug efflux pump through the inhibition of S‐S dependent homodimerization

  2002cited by this paper
• Mammalian ABC transporters in health and disease.

  2002cited by this paper
• Bryostatin-I—An Antineoplastic Treasure from the Deep?

  2002cited by this paper
• Resistance to multiple novel antifolates is mediated via defective drug transport resulting from clustered mutations in the reduced folate carrier gene in human leukaemia cell lines.

  2002influential reference
• The human ATP-binding cassette (ABC) transporter superfamily.

  2001cited by this paper
• Erratum: A multidrug resistance transporter from human MCF-7 breast cancer cells (Proceedings of the National Academy of Sciences of the USA (December 22, 1998) 95 (15665-15670))

  1999cited by this paper
• Molecular cloning of cDNAs which are highly overexpressed in mitoxantrone-resistant cells: demonstration of homology to ABC transport genes.

  1999cited by this paper
• A multidrug resistance transporter from human MCF-7 breast cancer cells.

  1998cited by this paper
• A human placenta-specific ATP-binding cassette gene (ABCP) on chromosome 4q22 that is involved in multidrug resistance.

  1998cited by this paper
• Efficiency of P-glycoprotein-mediated exclusion of rhodamine dyes from multidrug-resistant cells is determined by their passive transmembrane movement rate.

  1997cited by this paper
• Competition of Hydrophobic Peptides, Cytotoxic Drugs, and Chemosensitizers on a Common P-glycoprotein Pharmacophore as Revealed by Its ATPase Activity (*)

  1996cited by this paper
• The expanding role of quantitative structure-activity relationships (QSAR) in toxicology.

  1995cited by this paper
• Carrier- and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: correlates of molecular-structure and biological activity.

  1995cited by this paper
• Karnofsky memorial lecture. Ode to methotrexate.

  1993cited by this paper
• Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line.

  1992cited by this paper
• Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF7 human breast cancer cell line.

  1991cited by this paper
• Sequential amplification of dihydrofolate reductase and multidrug resistance genes in Chinese hamster ovary cells selected for stepwise resistance to the lipid-soluble antifolate trimetrexate.

  1989influential reference
• Cross-resistance to the lipid-soluble antifolate trimetrexate in human carcinoma cells with the multidrug-resistant phenotype.

  1989influential reference
• Characterization of trimetrexate transport in human lymphoblastoid cells and development of impaired influx as a mechanism of resistance to lipophilic antifolates.

  1988influential reference
• Biochemical and chemotherapeutic studies on 2,4-diamino-6-(2,5-dimethoxybenzyl)-5-methylpyrido[2,3-d]pyrimidine (BW 301U), a novel lipid-soluble inhibitor of dihydrofolate reductase.

  1982cited by this paper

• Overexpression of ABCG2 Confers Resistance to MLN7243, a Ubiquitin-Activating Enzyme (UAE) Inhibitor

  2021cites this paper
• Targeting multidrug resistance-associated protein 1 (MRP1)-expressing cancers: Beyond pharmacological inhibition.

  2021cites this paper
• Hypoxia as a driver of resistance to immunotherapy.

  2021cites this paper
• Overexpression of human ATP-binding cassette transporter ABCG2 contributes to reducing the cytotoxicity of GSK1070916 in cancer cells.

  2021cites this paper
• ABC Family Transporters.

  2019cites this paper
• Acyldepsipeptide Analogs Dysregulate Human Mitochondrial ClpP Protease Activity and Cause Apoptotic Cell Death.

  2018cites this paper
• Pyrimethamine Significantly Lowers CSF/SOD1 in ALS Patients With SOD1 Mutations

  2017cites this paper
• Pyrimethamine significantly lowers cerebrospinal fluid Cu/Zn superoxide dismutase in amyotrophic lateral sclerosis patients with SOD1 mutations

  2017cites this paper
• Roles of ATP binding cassette transporters in drug sensitivity and physiology of Plasmodium parasites

  2016cites this paper
• Role of ABC transporters in fluoropyrimidine-based chemotherapy response.

  2015cites this paper
• Microencapsulated Multicellular Tumor Spheroids as a Tool to Test Novel Anticancer Nanosized Drug Delivery Systems In Vitro.

  2015cites this paper
• Atovaquone and quinine anti-malarials inhibit ATP binding cassette transporter activity

  2014cites this paper
• Predicting substrates of the human breast cancer resistance protein using a support vector machine method

  2013cites this paper
• Synthesis and biological evaluation of novel antifolate analogs as potential anticancer treatment.

  2013cites this paper
• Human ABCG2: structure, function, and its role in multidrug resistance.

  2012cites this paper
• Antifolates in cancer therapy: structure, activity and mechanisms of drug resistance.

  2012cites this paper
• Chinese a Nti鄄 Cancer a Ssociation

  2012cites this paper
• In vitro and in vivo evidence for the importance of breast cancer resistance protein transporters (BCRP/MXR/ABCP/ABCG2).

  2011cites this paper
• Targeting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in cancer stem cells.

  2011cites this paper
• Identifying Compound-Target Associations by Combining Bioactivity Profile Similarity Search and Public Databases Mining

  2011cites this paper
• Contributions of TM5, ECL3 and TM6 of human BCRP to its oligomerization activities and transport functions

  2011cites this paper
• pH-Dependent Transport of Pemetrexed by Breast Cancer Resistance Protein

  2011cites this paper
• Cancer chemotherapy: targeting folic acid synthesis

  2010cites this paper
• The Emerging Role of the Phosphatidylinositol 3-Kinase/ Akt/Mammalian Target of Rapamycin Signaling Network in Cancer Stem Cell Biology

  2010cites this paper
• Synthesis and cytotoxic activity of N-((2-methyl-4(3H)-quinazolinon-6-yl)methyl)dithiocarbamates.

  2010cites this paper
• ACTIVE EFFLUX TRANSPORT AND CNS DISTRIBUTION OF THE NOVEL ANTIFOLATE PEMETREXED

  2010cites this paper
• Structural Determinants of Imidazoacridinones Facilitating Antitumor Activity Are Crucial for Substrate Recognition by ABCG2

  2009cites this paper
• The influence of carbohydrate ligands on the cytotoxicity of liposomes bearing a methotrexate-diglyceride conjugate in human acute leukemia cell cultures

  2009cites this paper
• ABCG2: the key to chemoresistance in cancer stem cells?

  2009cites this paper
• Liposomes loaded with lipophilic prodrugs of methotrexate and melphalan as convenient drug delivery vehicles

  2009cites this paper
• Folate deprivation induces BCRP (ABCG2) expression and mitoxantrone resistance in Caco‐2 cells

  2008cites this paper
• Liposomes as nanocarriers of lipid-conjugated antitumor drugs melphalan and methotrexate

  2008cites this paper
• [Liposomal formulation of a methotrexate diglyceride conjugate: activity in methotrexate-resistant leukemia cultured cells].

  2007cites this paper
• C421 allele-specific ABCG2 gene amplification confers resistance to the antitumor triazoloacridone C-1305 in human lung cancer cells.

  2007cites this paper
• Liposomal formulation of a methotrexate diglyceride conjugate: Activity toward a culture of methotrexate-resistant leukemia cells

  2007cites this paper
• The role of multidrug resistance efflux transporters in antifolate resistance and folate homeostasis.

  2006cites this paper
• Cancer Management and Research Dovepress Cancer Chemotherapy: Targeting Folic Acid Synthesis

  year unknowncites this paper